ATHEROSCLEROSIS - THE IMPORTANCE OF HDL CHOLESTEROL AND PROSTACYCLIN - A ROLE FOR NIACIN THERAPY

被引:6
|
作者
LURIA, MH
机构
[1] Department of Cardiology, Hadassah University Hospital, Jerusalem
关键词
D O I
10.1016/0306-9877(90)90062-J
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Niacin reduces the incidence of non-fatal myocardial way infarction, confers a significant long-term survival benefit after recovery from myocardial infarction, and has had many years of study and usage by the medical community. Recent evidence suggests that via mechanisms which elevate HDL cholesterol and also release endogenous prostacyclin, niacin should be a potent agent in the long-term treatment of atherosclerosis. © 1990.
引用
收藏
页码:21 / 28
页数:8
相关论文
共 50 条
  • [1] Niacin Therapy, HDL Cholesterol, and Cardiovascular Disease: Is the HDL Hypothesis Defunct?
    Preethi Mani
    Anand Rohatgi
    [J]. Current Atherosclerosis Reports, 2015, 17
  • [2] Niacin Therapy, HDL Cholesterol, and Cardiovascular Disease: Is the HDL Hypothesis Defunct?
    Mani, Preethi
    Rohatgi, Anand
    [J]. CURRENT ATHEROSCLEROSIS REPORTS, 2015, 17 (08)
  • [3] HDL cholesterol and atherosclerosis
    Mazzone, Theodore
    [J]. LANCET, 2007, 370 (9582): : 107 - 108
  • [4] Therapy and clinical trials: HDL-cholesterol and niacin therapy - past, present, and future
    Virani, Salim S.
    Ballantyne, Christie M.
    [J]. CURRENT OPINION IN LIPIDOLOGY, 2010, 21 (02) : 165 - 166
  • [5] Niacin and HDL Cholesterol - Time to Face Facts
    Lloyd-Jones, Donald M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (03): : 271 - 273
  • [6] Niacin therapy in atherosclerosis
    Meyers, CD
    Kamanna, VS
    Kashyap, ML
    [J]. CURRENT OPINION IN LIPIDOLOGY, 2004, 15 (06) : 659 - 665
  • [7] Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy
    Boden, William E.
    Probstfield, Jeffrey L.
    Anderson, Todd
    Chaitman, Bernard R.
    Desvignes-Nickens, Patrice
    Koprowicz, Kent
    McBride, Ruth
    Teo, Koon
    Weintraub, William
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (24): : 2255 - 2267
  • [8] Raising HDL-cholesterol: the future drug therapy for atherosclerosis?
    Masson, David
    Yvan-Charvet, Laurent
    [J]. M S-MEDECINE SCIENCES, 2008, 24 (04): : 341 - 343
  • [9] EFFECT OF NIACIN ON HDL-CHOLESTEROL AND HDL-APO AI
    Kashyap, M.
    Zhang, L.
    Kamanna, V.
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [10] New insights into the role of HDL in reverse cholesterol transport and atherosclerosis
    Brewer, HB
    [J]. ATHEROSCLEROSIS, 1999, 144 : 6 - 6